Ocular drug delivery
Open accessAbstract
Ocular drug delivery has been a major challenge to pharmacologists and drug delivery scientists due to its unique anatomy and physiology. Static barriers (different layers of cornea, sclera, and retina including blood aqueous and blood-retinal barriers), dynamic barriers (choroidal and conjunctival blood flow, lymphatic clearance, and tear dilution), and efflux pumps in conjunction pose a significant challenge for delivery of a drug alone or in a dosage form, especially to the posterior segment. Identification of influx transporters on various ocular tissues and designing a transporter-targeted delivery of a parent drug has gathered momentum in recent years. Parallelly, colloidal dosage forms such as nanoparticles, nanomicelles, liposomes, and microemulsions have been widely explored to overcome various static and dynamic barriers. Novel drug delivery strategies such as bioadhesive gels and fibrin sealant-based approaches were developed to sustain drug levels at the target site. Designing noninvasive sustained drug delivery systems and exploring the feasibility of topical application to deliver drugs to the posterior segment may drastically improve drug delivery in the years to come. Current developments in the field of ophthalmic drug delivery promise a significant improvement in overcoming the challenges posed by various anterior and posterior segment diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Topical administration avoids first-pass metabolism and has easy administration, but barriers reduce bioavailability to around 5% or less.
“This method avoids complications of first-pass metabolism and has the advantage of easy administration, sometimes by the patients themselves. However, barriers, such as the pre-corneal tear film, the structure of the cornea, limited volume, lacrimal drainage system, reflex tearing, and aqueous outflow of the eye, reduce the bioavailability of the product to around 5% or less.35,118,119”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
Most gene therapy viral vectors given intravitreally fail to adequately transduce photoreceptors and RPE due to the inner limiting membrane.
“Most gene therapy viral vectors given intravitreally, fail to adequately transduce photoreceptors and RPE, due to the inner limiting membrane that divides the vitreous from the retina.1,15,119,127”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
Intravitreal injections carry risks of adverse reactions including inflammation, endophthalmitis, increased intraocular pressure, retinal detachment, hemorrhage, and cataracts, and patient compliance can become an issue due to repeated use.
“Despite these advantages, intravitreal injections also carry risks of adverse reactions, including inflammation, endophthalmitis, increased intraocular pressure, retinal detachment, hemorrhage, and cataracts, and due to the repeated use of these injections in various treatments, patient compliance can become an issue.119,127,129”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Part of this paper’s reference list could not be split into single entries.
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506 · see citing works
Cyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375 · see citing works
Cyclodextrins and their pharmaceutical applications
Loftsson, Þ., & Duchêne, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,766 · see citing works
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,645 · see citing works
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115 · see citing works
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003 · see citing works
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 630 · see citing works
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S., & Mitra, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 600 · see citing works
Self-citationSieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 591 · see citing works
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
Lee, V. H. L., & Robinson, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 504 · see citing works
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A. B., Singla, A. K., & Aggarwal, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450 · see citing works
Viral Vectors for Gene Transfer
Walther, W., & Stein, U. (2000) · Drugs · doi:10.2165/00003495-200060020-00002 · Cited by 444 · see citing works
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. O. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414 · see citing works
Vandamme, T. F., & Brobeck, L. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 402 · see citing works
Topical and systemic drug delivery to the posterior segments
HUGHES, P., OLEJNIK, O., Chang-Lin, J.-E., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400 · see citing works
Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357 · see citing works
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 350 · see citing works
Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
Hathout, R. M., Mansour, S., Mortada, N. D., & Guinedi, A. S. (2007) · AAPS PharmSciTech · doi:10.1208/pt0801001 · Cited by 346 · see citing works
Ghate, D. A., & Edelhauser, H. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.275 · Cited by 336 · see citing works
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I. A., Mireskandari, K., Luthert, P. J., Duncan, R., Patterson, S., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt995 · Cited by 331 · see citing works
Suprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330 · see citing works
Role of Mucins in the Function of the Corneal and Conjunctival Epithelia
Gipson, I. K., & Argüeso, P. (2003) · International review of cytology · doi:10.1016/s0074-7696(03)31001-0 · Cited by 323 · see citing works
Juillerat‐Jeanneret, L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.005 · Cited by 313 · see citing works
Ocular novel drug delivery: impacts of membranes and barriers
Barar, J., Javadzadeh, A., & Omidi, Y. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.567 · Cited by 309 · see citing works
Ophthalmic Drug Delivery through Contact Lenses
Gulsen, D., & Chauhan, A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0959 · Cited by 305 · see citing works
Biodegradable Implants for Sustained Drug Release in the Eye
Lee, S. S., Hughes, P. M., Ross, A. D., & Robinson, M. R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0159-x · Cited by 288 · see citing works
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
Ahmed, I., & Patton, T. F. (1985) · PubMed · Cited by 287 · see citing works
Interaction Between Chemicals and Melanin
LARSSON, B. S. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00591.x · Cited by 287 · see citing works
Coated Microneedles for Drug Delivery to the Eye
Jiang, J., Gill, H. S., Ghate, D. A., McCarey, B. E., Patel, S. R., Edelhauser, H. F., & Prausnitz, M. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0066 · Cited by 286 · see citing works
Transscleral drug delivery for posterior segment disease
Geroski, D. H., & Edelhauser, H. F. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00193-4 · Cited by 282 · see citing works
Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle
Gulsen, D., & Chauhan, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.033 · Cited by 277 · see citing works
Talcott, K. E., Ratnam, K., Sundquist, S. M., Lucero, A. S., Lujan, B. J., Tao, W., Porco, T. C., Roorda, A., & Duncan, J. L. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6479 · Cited by 276 · see citing works
Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP)
Diebold, Y., Jarrı́n, M., Sáez, V., Carvalho, E. L. S., Orea, M. J., Calonge, M., Seijo, B., & Alonso, M. J. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.028 · Cited by 273 · see citing works
Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity
Pitka¨nen, L., Ranta, V.-P., Moilanen, H., & Urtti, A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1051 · Cited by 261 · see citing works
Kompella, U., Bandi, N., & Ayalasomayajula, S. (2003) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.02-0791 · Cited by 259 · see citing works
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257 · see citing works
Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery
Li, N., Zhuang, C.-Y., Wang, M., Sun, X., Nie, S., & Pan, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.020 · Cited by 248 · see citing works
Drug delivery to the retina: challenges and opportunities
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.45 · Cited by 238 · see citing works
Self-citationIntraocular implants for extended drug delivery: Therapeutic applications
Bourges, J., Bloquel, C., Thomas, A., Froussart, F., Bochot, A., Azan, F., Gurny, R., BenEzra, D., & Béhar‐Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.026 · Cited by 235 · see citing works
Sammalkorpi, M., Karttunen, M., & Haataja, M. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp901228v · Cited by 235 · see citing works
Kim, J. H., Kim, J. H., Kim, K., Kim, M. H., & Yu, Y. S. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/50/505101 · Cited by 228 · see citing works
Amrite, A. C., & Kompella, U. B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.12.0005 · Cited by 213 · see citing works
Intrascleral Drug Delivery to the Eye Using Hollow Microneedles
Jiang, J., Moore, J. S., Edelhauser, H. F., & Prausnitz, M. R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9756-3 · Cited by 209 · see citing works
Singh, S. R., GROSSNIKLAUS, H. E., Kang, S. J., Edelhauser, H. F., Ambati, B. K., & Kompella, U. B. (2009) · Gene Therapy · doi:10.1038/gt.2008.185 · Cited by 204 · see citing works
Weber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203 · see citing works
Acyclovir-containing liposomes for potential ocular delivery
Law, S. L., Huang, K.-J., & Chiang, C. ‐. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00192-3 · Cited by 202 · see citing works
Bainbridge, J., Stephens, C., Parsley, K., Demaison, C., Halfyard, A., Thrasher, A., & Ali, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301574 · Cited by 197 · see citing works
Gan, L., Han, S., Shen, J., Zhu, J., Zhu, C., Zhang, X., & Gan, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.015 · Cited by 197 · see citing works
Acetazolamide: future perspective in topical glaucoma therapeutics
Kaur, I. P., Smitha, R., Aggarwal, D., & Kapil, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00438-6 · Cited by 194 · see citing works
AAV hybrid serotypes: improved vectors for gene delivery
Choi, V., McCarty, D., & Samulski, R. (2005) · Current Gene Therapy · doi:10.2174/1566523054064968 · Cited by 191 · see citing works
Vitreous: A Barrier to Nonviral Ocular Gene Therapy
Peeters, L., Sanders, N. N., Braeckmans, K., Boussery, K., Van de Voorde, J., De Smedt, S. C., & Demeester, J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0165 · Cited by 189 · cited 2× · see citing works
“Polystyrene nanospheres do not diffuse freely into the vitreous due to their adherence to collagen fibrillar structures (39).”
BackgroundYang, H., Morris, J. J., & Lopina, S. T. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2003.12.023 · Cited by 185 · see citing works
Transport processes across the rabbit corneal epithelium: a review
Klyce, S. D., & Crosson, C. E. (1985) · Current Eye Research · doi:10.3109/02713688509025145 · Cited by 185 · see citing works
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection
Weijtens, O., Feron, E. J., Schoemaker, R. C., Cohen, A. F., Lentjes, E. G. W. M., Romijn, F. P. H. T. M., & van Meurs, J. C. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00129-4 · Cited by 184 · see citing works
Huang, X. B., & Lowe, T. L. (2005) · Biomacromolecules · doi:10.1021/bm050116t · Cited by 181 · see citing works
Binding of Drugs to Eye Melanin Is Not Predictive of Ocular Toxicity
Leblanc, B., Jezequel, S. G., Davies, T., Hanton, G. C., & Taradach, C. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1243 · Cited by 179 · see citing works
Kim, H., Robinson, S. B., & Csaky, K. G. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9745-6 · Cited by 174 · see citing works
Transport Barriers in Transscleral Drug Delivery for Retinal Diseases
Kim, S. H., Lutz, R. J., Wang, N. S., & Robinson, M. R. (2007) · Ophthalmic Research · doi:10.1159/000108117 · Cited by 173 · see citing works
Yiyun, C., & Xu, T. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.06.010 · Cited by 168 · see citing works
Liposomes in topical drug delivery.
Schaeffer, H. E., & Krohn, D. L. (1982) · PubMed · Cited by 167 · see citing works
Gupta, A. K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00508-1 · Cited by 160 · see citing works
Dispersion of DMPC Liposomes in Contact Lenses for Ophthalmic Drug Delivery
Gulsen, D., Li, C., & Chauhan, A. (2005) · Current Eye Research · doi:10.1080/02713680500346633 · Cited by 159 · see citing works
Jaffe, G. J., McCallum, R. M., Branchaud, B., Skalak, C., Butuner, Z., & Ashton, P. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.03.013 · Cited by 158 · see citing works
Zhang, T., Xiang, C. D., Gale, D. C., Carreiro, S. T., Wu, E. Y., & Zhang, E. Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021121 · Cited by 156 · see citing works
Colloidal Carriers for Ophthalmic Drug Delivery
Mainardes, R. M., Urban, M. C. C., Cinto, P. O., Khalil, N. M., Chaud, M. V., Evangelista, R. C., & Gremião, M. P. D. (2005) · Current Drug Targets · doi:10.2174/1389450053765914 · Cited by 155 · see citing works
Gene delivery to the eye using adeno-associated viral vectors
Martin, K. R. G., Klein, R. L., & Quigley, H. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00232-3 · Cited by 149 · see citing works
Distribution of peptide transporter PEPT2 mRNA in the rat nervous system
Berger, U. V., & Hediger, M. A. (1999) · Anatomy and Embryology · doi:10.1007/s004290050242 · Cited by 146 · see citing works
Gene therapy progress and prospects: the eye
Bainbridge, J. W., Tan, M. H., & Ali, R. R. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302812 · Cited by 144 · see citing works
Chévez-Barrios, P., Chintagumpala, M., Mieler, W., Paysse, E., Boniuk, M., Kozinetz, C., Hurwitz, M. Y., & Hurwitz, R. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.1883 · Cited by 143 · see citing works
Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers
Lopez, A. I., Reins, R. Y., McDermott, A. M., Trautner, B. W., & Cai, C. (2009) · Molecular BioSystems · doi:10.1039/b904746h · Cited by 142 · see citing works
Ayalasomayajula, S. P., & Kompella, U. B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.019 · Cited by 140 · see citing works
Choonara, Y. E., Pillay, V., Danckwerts, M. P., Carmichael, T. R., & du Toit, L. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21987 · Cited by 139 · see citing works
Cationic Vectors in Ocular Drug Delivery
Rabinovich‐Guilatt, L., Couvreur, P., Lambert, G., & Dubernet, C. (2004) · Journal of drug targeting · doi:10.1080/10611860400015910 · Cited by 139 · see citing works
Vitreous Is a Barrier in Nonviral Gene Transfer by Cationic Lipids and Polymers
Pitkänen, L., Ruponen, M., Nieminen, J., & Urtti, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1023238530504 · Cited by 134 · see citing works
Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery
Nagarsenker, M. S., Londhe, V. Y., & Nadkarni, G. D. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00265-3 · Cited by 134 · see citing works
Aburahma, M. H., & Mahmoud, A. A. K. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9701-3 · Cited by 133 · see citing works
P-glycoprotein expression in human retinal pigment epithelium.
Kennedy, B. G., & Mangini, N. J. (2002) · PubMed · Cited by 130 · see citing works
PLGA–PEG–PLGA hydrogel for ocular drug delivery of dexamethasone acetate
Gao, Y., Sun, Y., Ren, F., & Gao, S. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003680826 · Cited by 130 · see citing works
Dey, S., Patel, J., Anand, B. S., Jain-Vakkalagadda, B., Kaliki, P., Pal, D., Ganapathy, V., & Mitra, A. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1142 · Cited by 128 · see citing works
Self-citationZhang, J., & Wang, S. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.001 · Cited by 128 · see citing works
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125 · see citing works
Liaw, J., Chang, S.-F., & Hsiao, F.-C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301485 · Cited by 125 · see citing works
Sigurðsson, H. H., Konrádsdóttir, F., Loftsson, Þ., & Stefánsson, E. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2007.00885.x · Cited by 122 · see citing works
Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels
KIM, J., & Chauhan, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.049 · Cited by 120 · see citing works
Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes
Acheampong, A., Shackleton, M., John, B. A., Burke, J. E., Wheeler, L. A., & Tang-Liu, D. D.-S. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.421 · Cited by 120 · see citing works
Bemelmans, A., Kostic, C., Crippa, S. V., Hauswirth, W. W., Lem, J., Munier, F. L., Seeliger, M. W., Wenzel, A., & Arsenijévic, Y. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030347 · Cited by 118 · see citing works
van Adel, B. A., Kostic, C., Déglon, N., Ball, A. K., & Arsenijévic, Y. (2003) · Human Gene Therapy · doi:10.1089/104303403321070801 · Cited by 114 · see citing works
Mannis, M. J. (1993) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71425-4 · Cited by 110 · see citing works
Loftsson, Þ., Hreinsdóttir, D., & Stefánsson, E. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.5.0002 · Cited by 110 · see citing works
Lotery, A. J., Yang, G. S., Mullins, R. F., Russell, S. R., Schmidt, M., Stone, E. M., Lindbloom, J. D., Chiorini, J. A., Kotin, R. M., & Davidson, B. L. (2003) · Human Gene Therapy · doi:10.1089/104303403322542301 · Cited by 107 · see citing works
Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0404 · Cited by 107 · see citing works
Nanoparticle applications in ocular gene therapy
Cai, X., Conley, S. M., & Naash, M. I. (2007) · Vision Research · doi:10.1016/j.visres.2007.07.012 · Cited by 106 · see citing works
Preparation and ocular pharmacokinetics of ganciclovir liposomes
Shen, Y., & Tu, J. (2007) · The AAPS Journal · doi:10.1208/aapsj0903044 · Cited by 106 · see citing works
Anand, B. S., & Mitra, A. K. (2002) · Pharmaceutical Research · doi:10.1023/a:1019806411610 · Cited by 105 · see citing works
Self-citationOcular gene delivery using lentiviral vectors
Balaggan, K. S., & Ali, R. R. (2011) · Gene Therapy · doi:10.1038/gt.2011.153 · Cited by 104 · see citing works
Molecular Design for Enhancement of Ocular Penetration
Shirasaki, Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21200 · Cited by 100 · see citing works
Natarajan, J. V., Chattopadhyay, S., Ang, M., Darwitan, A., Foo, S. E. M., Zhen, M., Koo, M., Wong, T. T. L., & Venkatraman, S. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024513 · Cited by 100 · see citing works
Koevary, S. B. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489488 · Cited by 99 · see citing works
Zhang, R., He, R., Jiang, Q., Guo, J., Xue, K., & Yuan, Y.-F. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4373 · Cited by 98 · see citing works
Derwent, J. J. K., & Mieler, W. F. (2008) · PubMed · Cited by 97 · see citing works
Misra, G. P., Singh, R. S., Alemán, T. S., Jacobson, S. G., Gardner, T. W., & Lowe, T. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.025 · Cited by 96 · see citing works
Effect of Eye Pigmentation on Transscleral Drug Delivery
Cheruvu, N. P. S., Amrite, A. C., & Kompella, U. B. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0214 · Cited by 95 · see citing works
Vitreous Penetration of Orally Administered Valacyclovir
Huynh, T. H., Johnson, M. W., Comer, G. M., & Fish, D. N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.11.016 · Cited by 94 · see citing works
A Nonionic Surfactant/Chitosan Micelle System in an Innovative Eye Drop Formulation
Pepić, I., Hafner, A., Lovrić, J., Pirkić, B., & Filipović‐Grčić, J. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22137 · Cited by 94 · see citing works
Marano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Tóth, I., Brankov, M., & Rakoczy, P. E. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.06.023 · Cited by 93 · see citing works
Zhang, L. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s6428 · Cited by 93 · see citing works
Subconjunctival Carboplatin in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
VANQUILL, K., Dioguardi, P. K., TONG, C., Gilbert, J. A., AABERGJR, T., Grossniklaus, H. E., EDELHAUSER, H., & OBRIEN, J. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.060 · Cited by 91 · see citing works
Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives
Rolling, F. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302366 · Cited by 90 · see citing works
Kinetics of macromolecules injected into the subretinal space
Marmor, M. F., Negi, A., & Maurice, D. M. (1985) · Experimental Eye Research · doi:10.1016/0014-4835(85)90138-1 · Cited by 90 · see citing works
Ocular Drug Delivery; Impact of in vitro Cell Culture Models.
Barar, J., Asadi, M., Mortazavi‐Tabatabaei, S. A., & Omidi, Y. (2009) · PubMed Central · Cited by 90 · see citing works
Durairaj, C., Kadam, R. S., Chandler, J., Hutcherson, S. L., & Kompella, U. B. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5388 · Cited by 86 · see citing works
Oral omega-6 essential fatty acid treatment in contact lens associated dry eye
Kokke, K. H., Morris, J. A., & Lawrenson, J. G. (2008) · Contact Lens and Anterior Eye · doi:10.1016/j.clae.2007.12.001 · Cited by 86 · see citing works
Dey, S., Gunda, S., & Mitra, A. K. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069583 · Cited by 85 · see citing works
Self-citationMicellar solutions of triblock copolymer surfactants with pilocarpine
Pepić, I., Jalšenjak, N., & Jalšenjak, I. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.032 · Cited by 84 · see citing works
Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors
Balaggan, K. S., Binley, K. E., Esapa, M., Iqball, S., Askham, Z., Kan, O., Tschernutter, M., Bainbridge, J. W., Naylor, S., & Ali, R. R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.845 · Cited by 83 · see citing works
Aukunuru, J., Sunkara, G., Bandi, N., Thoreson, W. B., & Kompella, U. B. (2001) · Pharmaceutical Research · doi:10.1023/a:1011060705599 · Cited by 82 · see citing works
Preparation and characterization of puerarin–dendrimer complexes as an ocular drug delivery system
Yao, W., Sun, K., Mu, H., Liang, N., Liu, Y., Chen, Y., Liang, R., & Wang, A. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003610799 · Cited by 82 · see citing works
Tirucherai, G., & Mitra, A. K. (2003) · AAPS PharmSciTech · doi:10.1208/pt040345 · Cited by 81 · see citing works
Self-citationTakahashi, K. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.27 · Cited by 80 · see citing works
Charged nanoparticles delivery to the eye using hydrogel iontophoresis
Eljarrat‐Binstock, E., Orucov, F., Aldouby, Y., Frucht‐Pery, J., & Domb, A. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.016 · Cited by 78 · see citing works
Usayapant, A., Karara, A. H., & Narurkar, M. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015838215268 · Cited by 77 · see citing works
Kompella, U. B., Sundaram, S., Raghava, S., & Escobar, E. R. (2006) · PubMed · Cited by 77 · see citing works
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate
Dalpiaz, A., Filosa, R., Caprariis, P. D., Conte, G. M., Bortolotti, F., Biondi, C., Scatturin, A., Prasad, P. D., & Pavan, B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.051 · Cited by 76 · see citing works
Kim, S. H., Csaky, K. G., Wang, N. S., & Lutz, R. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9408-z · Cited by 74 · see citing works
A primary culture model of rabbit conjunctival epithelial cells exhibiting tight barrier properties
Saha, P., Kim, K.-J., & Lee, V. H. L. (1996) · Current Eye Research · doi:10.3109/02713689608995151 · Cited by 73 · see citing works
Cappello, B., Carmignani, C., Iervolino, M., Rotonda, M. I. L., & Saettone, M. F. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00648-7 · Cited by 72 · see citing works
Yang, J. J., Kim, K.-J., & Lee, V. H. L. (2000) · Pharmaceutical Research · doi:10.1023/a:1007508714259 · Cited by 70 · see citing works
Kawazu, K., Yamada, K., Nakamura, M., & Ota, A. (1999) · PubMed · Cited by 70 · see citing works
Anand, B. S., Patel, J., & Mitra, A. K. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044313 · Cited by 70 · see citing works
Self-citationXiang, C. D., Batugo, M. R., Gale, D. C., Zhang, T., Ye, J., Li, C., Zhou, S., Wu, E. Y., & Zhang, E. Y. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026286 · Cited by 70 · see citing works
Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells.
Saha, P., Yang, J. J., & Lee, V. H. L. (1998) · PubMed · Cited by 68 · see citing works
Majumdar, S., Nashed, Y. E., Patel, K., Jain, R., Itahashi, M., Neumann, D. M., Hill, J. M., & Mitra, A. K. (2005) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2005.21.463 · Cited by 68 · see citing works
Self-citationP-Glycoprotein expression in human retinal pigment epithelium cell lines
Constable, P. A., Lawrenson, J. G., Dolman, D. E. M., Arden, G. B., & Abbott, N. J. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.029 · Cited by 68 · see citing works
Freeze-fracture quantitative comparison of rabbit corneal epithelial and endothelial membranes
McLaughlin, B. J., Caldwell, R. B., Sasaki, Y., & Wood, T. O. (1985) · Current Eye Research · doi:10.3109/02713689509000002 · Cited by 68 · see citing works
Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits
Loftsson, Þ., Friðriksdóttir, H., Stefánsson, E., Thórisdóttir, S., Gudmundsson, Ó. S., & Sigthórsson, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03835.x · Cited by 65 · see citing works
Lönngren, U., Näpänkangas, U., Lafuente, M. P., Mayor, S., Lindqvist, N., Vidal‐Sanz, M., & Hallböök, F. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.09.005 · Cited by 65 · see citing works
Intravitreal Pharmacokinetics of Plain and Liposome-Entrapped Fluconazole in Rabbit Eyes
Gupta, S. K., Velpandian, T., Dhingra, N., & Jaiswal, J. K. (2000) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2000.16.511 · Cited by 64 · see citing works
Current prodrug strategies via membrane transporters/receptors
Anand, B. S., Dey, S., & Mitra, A. K. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.6.607 · Cited by 63 · see citing works
Self-citationGoldblum, D., Rohrer, K., Frueh, B. E., Theurillat, R., Thormann, W., & Zimmerli, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3719-3723.2002 · Cited by 63 · see citing works
Effluxing ABC transporters in human corneal epithelium
Vellonen, K., Mannermaa, E., Turner, H. C., Häkli, M., Wolosin, J. M., Tervo, T., Honkakoski, P., & Urtti, A. O. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21878 · Cited by 62 · see citing works
Jansen, T., Xhonneux, B., Mesens, J., & Borgers, M. J. (1990) · PubMed · Cited by 60 · see citing works
Reer, O., Bock, T. K., & Müller, B. W. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830928 · Cited by 60 · see citing works
Furrer, E., Berdugo, M., Stella, C., Béhar‐Cohen, F., Gurny, R., Feige, U., Lichtlen, P., & Urech, D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2370 · Cited by 59 · see citing works
Santulli, R. J., Kinney, W. A., Ghosh, S., DeCorte, B. L., Liu, L., Tuman, R. W., Zhao, Z., Huebert, N. D., Bursell, S. E., Clermont, A. C., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131656 · Cited by 59 · see citing works
Karla, P. K., Pal, D., Quinn, T., & Mitra, A. K. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.031 · Cited by 59 · see citing works
Self-citationStable RAAV-Mediated Transduction of Rod and Cone Photoreceptors in the Canine Retina
Bainbridge, J. W. B., Mistry, A., Schlichtenbrede, F. C., Smith, A., Broderick, C., De Alwis, M., Georgiadis, A., Taylor, P. M., Squires, M., Sethi, C., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301990 · Cited by 58 · see citing works
Karla, P. K., Earla, R., Boddu, S. H., Johnston, T. P., Pal, D., & Mitra, A. K. (2009) · Current Eye Research · doi:10.1080/02713680802518251 · Cited by 58 · see citing works
Self-citationJain-Vakkalagadda, B., Pal, D., Gunda, S., Nashed, Y. E., Ganapathy, V., & Mitra, A. K. (2004) · Molecular Pharmaceutics · doi:10.1021/mp0499499 · Cited by 57 · see citing works
Self-citationSubconjunctival Topotecan in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
Tsui, J. Y., Dalgard, C. L., Quill, K. R. V., Lee, L., Grossniklaus, H. E., Edelhauser, H. F., & O’Brien, J. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0653 · Cited by 57 · see citing works
Ultrasound-Enhanced Transcorneal Drug Delivery
Zderic, V., Clark, J. I., Martin, R. W., & Vaezy, S. (2004) · Cornea · doi:10.1097/01.ico.0000134189.33549.cc · Cited by 57 · see citing works
Pitkänen, L., Ranta, V., Moilanen, H., & Urtti, A. O. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9342-0 · Cited by 56 · see citing works
Garrett, Q., Xu, S., Simmons, P. A., Vehige, J. G., Flanagan, J., & Willcox, M. D. P. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1528 · Cited by 55 · see citing works
Doxycycline-Mediated Inhibition of Choroidal Neovascularization
Samtani, S., Amaral, J., Campos, M. M., Fariss, R. N., & Becerra, S. P. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3174 · Cited by 55 · see citing works
Transscleral Diffusion of Carboplatin
Simpson, A. E. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.8.1069 · Cited by 55 · see citing works
Jain-Vakkalagadda, B., Dey, S., Pal, D., & Mitra, A. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0907 · Cited by 54 · see citing works
Self-citationKatragadda, S., Talluri, R. S., & Mitra, A. K. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.110 · Cited by 54 · see citing works
Self-citationTrittibach, P. C., Barker, S. E., Broderick, C. A., Natkunarajah, M., Durán, Y., Robbie, S. J., Bainbridge, J. W., Smith, A. J., Sarra, G., Dick, A. D., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.109 · Cited by 54 · see citing works
Gunda, S., Hariharan, S., & Mitra, A. K. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.465 · Cited by 52 · see citing works
Self-citationTreatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
Ausayakhun, S., Yuvaves, P., Ngamtiphakom, S., & Prasitsilp, J. (2005) · PubMed · Cited by 52 · see citing works
Janoria, K. G., Boddu, S. H. S., Wang, Z., Paturi, D., Samanta, S., Pal, D., & Mitra, A. K. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0040 · Cited by 51 · see citing works
Self-citationCheng, L., Hostetler, K. Y., Chaidhawangul, S., Gardner, M. F., Beadle, J. R., Keefe, K., Bergeron-Lynn, G., SEVERSON, G. M., Soules, K. A., Mueller, A. J., et al. (2000) · PubMed · Cited by 49 · see citing works
Talluri, R. S., Samanta, S., Gaudana, R., & Mitra, A. K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.024 · Cited by 49 · see citing works
Self-citationBary, A. R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00108-9 · Cited by 49 · see citing works
Barraza, R., Rasmussen, C. A., Loewen, N. A., Cameron, J. D., Gabelt, B. T., Teo, W., Kaufman, P. L., & Poeschla, E. M. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.086 · Cited by 48 · see citing works
Loewen, N. A., Bahler, C. K., Teo, W., Whitwam, T., Peretz, M., Xu, R., Fautsch, M. P., Johnson, D. H., & Poeschla, E. M. (2002) · PubMed · Cited by 47 · see citing works
Tirucherai, G., Dias, C. S., & Mitra, A. K. (2002) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076802321021081 · Cited by 47 · see citing works
Self-citationHolló, G., Whitson, J. T., Faulkner, R. D., McCue, B. A., Curtis, M., Wieland, H., Chastain, J. E., Sanders, M., DeSantis, L. M., Przydryga, J., et al. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0945 · Cited by 47 · see citing works
Expression of Multidrug Resistance Associated Protein 5 (MRP5) on Cornea and Its Role in Drug Efflux
Karla, P. K., Quinn, T., Herndon, B., Thomas, P., Pal, D., & Mitra, A. K. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0084 · Cited by 47 · see citing works
Self-citationMitra, A. K., Anand, B. S., & Duvvuri, S. (2005) · Advances in organ biology · doi:10.1016/s1569-2590(05)10012-3 · Cited by 46 · see citing works
Self-citationMajumdar, S., Hingorani, T., Srirangam, R., Gadepalli, R. S., Rimoldi, J. M., & Repka, M. A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9730-0 · Cited by 46 · see citing works
Boddu, S. H. S., Jwala, J., Chowdhury, M. R., & Mitra, A. K. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0048 · Cited by 46 · see citing works
Self-citationOcular Pharmacokinetics of Cephalosporins using Microdialysis
Macha, S., & Mitra, A. K. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076801753266866 · Cited by 46 · see citing works
Self-citationLoewen, N. A., Fautsch, M. P., Teo, W., Bahler, C. K., Johnson, D. H., & Poeschla, E. M. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0366 · Cited by 46 · see citing works
Transcorneal Iontophoresis for Delivery of Ciprofloxacin Hydrochloride
Vaka, S. R. K., Sammeta, S. M., Day, L. B., & Murthy, S. N. (2008) · Current Eye Research · doi:10.1080/02713680802270945 · Cited by 46 · see citing works
Functional and molecular analysis of d-serine transport in retinal Müller cells
Dun, Y., Mysona, B. A., Itagaki, S., Martin-Studdard, A., Ganapathy, V., & Smith, S. B. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.09.015 · Cited by 46 · see citing works
Anand, B. S., Katragadda, S., Nashed, Y. E., & Mitra, A. K. (2004) · Current Eye Research · doi:10.1080/02713680490504614 · Cited by 46 · see citing works
Self-citationVoigt, M., de Kozak, Y., Halhal, M., Courtois, Y., & Béhar‐Cohen, F. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00656-3 · Cited by 45 · see citing works
Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine
Duvvuri, S., Gandhi, M. D., & Mitra, A. K. (2003) · Current Eye Research · doi:10.1076/ceyr.27.6.345.18187 · Cited by 45 · see citing works
Self-citationHosseini, K., Matsushima, D., Johnson, J. A., Widera, G., Nyam, K., Kim, L., Xu, Y., Yao, Y., & Cormier, M. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2007.0117 · Cited by 45 · see citing works
Vitreous Penetration of Orally Administered Famciclovir
Chong, D. Y., Johnson, M. W., Huynh, T. H., Hall, E. F., Comer, G. M., & Fish, D. N. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.02.010 · Cited by 45 · see citing works
Expression of ABC-Transporters in Human Corneal Tissue and the Transformed Cell Line, HCE-T
Becker, U., Ehrhardt, C., Schneider‐Daum, N., Baldes, C., Schaefer, U. F., Ruprecht, K. W., Kim, K., & Lehr, C. (2007) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.0095 · Cited by 45 · see citing works
Widespread expression of an exogenous gene in the eye after intravenous administration.
Zhu, C., Zhang, Y., & Pardridge, W. M. (2002) · PubMed · Cited by 44 · see citing works
Sustained Subconjunctival Protein Delivery Using a Thermosetting Gel Delivery System
Rieke, E. R., Amaral, J., Becerra, S. P., & Lutz, R. J. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2009.0059 · Cited by 44 · see citing works
Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix
Gilbert, J. A., Simpson, A. E., Rudnick, D. E., Geroski, D. H., Aaberg, T. M., & Edelhauser, H. F. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00151-2 · Cited by 44 · see citing works
Chew, E. Y., Glassman, A. R., Beck, R. W., Bressler, N. M., Fish, G. E., Ferris, F. L., & Kinyoun, J. L. (2010) · Retina · doi:10.1097/iae.0b013e3181f049a8 · Cited by 44 · see citing works
Penetration of moxifloxacin into the human aqueous humour after oral administration
Kampougeris, G. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.050054 · Cited by 44 · see citing works
Novel Nanoparticulate Gel Formulations of Steroids for the Treatment of Macular Edema
Boddu, S. H. S., Jwala, J., Vaishya, R. D., Earla, R., Karla, P. K., Pal, D., & Mitra, A. K. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2009.0074 · Cited by 42 · see citing works
Self-citationMethylprednisolone Delivery to the Back of the Eye using Hydrogel Iontophoresis
Eljarrat‐Binstock, E., Orucov, F., Frucht‐Pery, J., Pe’er, J., & Domb, A. J. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2007.0097 · Cited by 42 · see citing works
Methotrexate Delivery to the Eye Using Transscleral Hydrogel Iontophoresis
Eljarrat‐Binstock, E., Domb, A. J., Orucov, F., Frucht‐Pery, J., & Pe’er, J. (2007) · Current Eye Research · doi:10.1080/02713680701528674 · Cited by 42 · see citing works
Aqueous and Vitreous Penetration of Levofloxacin after Topical and/or Oral Administration
Sakamoto, H., Sakamoto, M., Hata, Y., Kubota, T., & Ishibashi, T. (2007) · European Journal of Ophthalmology · doi:10.1177/112067210701700316 · Cited by 40 · see citing works
Valls, R., Vega, E., García, M. L., Egea, M. A., & Vall�s, J. (2008) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104500802010066 · Cited by 40 · see citing works
Mishra, G. P., Tamboli, V., & Mitra, A. K. (2011) · Colloid & Polymer Science · doi:10.1007/s00396-011-2476-y · Cited by 40 · see citing works
Self-citationTalluri, R. S., Katragadda, S., Pal, D., & Mitra, A. K. (2006) · Current Eye Research · doi:10.1080/02713680600693629 · Cited by 40 · see citing works
Self-citationOcular distribution of intravenously administered micafungin in rabbits
Suzuki, T., Uno, T., Chen, G., & Ohashi, Y. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-008-0612-5 · Cited by 40 · see citing works
Ocular Sustained Release Nanoparticles Containing Stereoisomeric Dipeptide Prodrugs of Acyclovir
Jwala, J., Boddu, S. H. S., Shah, S. J., Sirimulla, S., Pal, D., & Mitra, A. K. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0188 · Cited by 39 · see citing works
Self-citationFibrin-Enmeshed Tobramycin Liposomes: Single Application Topical Therapy of Pseudomonas Keratitis
Frucht-Perry, J., Assil, K. K., Ziegler, E. J., Douglas, H., Brown, S. I., Schanzlin, D. J., & Weinreb, R. N. (1992) · Cornea · doi:10.1097/00003226-199209000-00006 · Cited by 39 · see citing works
Does orally administered doxycycline reach the tear film?
Smith, V. A., Khan-Lim, D., Anderson, L., Cook, S. D., & Dick, A. D. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.125989 · Cited by 39 · see citing works
Harrison, S. C. (2010) · Science · doi:10.1126/science.1194922 · Cited by 38 · see citing works
Effect of Poly(amidoamine) Dendrimers on Corneal Penetration of Puerarin
Yao, W., Sun, K., Liu, Y., Liang, N., Mu, H., Yao, C., Liang, R., & Wang, A. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1371 · Cited by 38 · see citing works
Hughes, P. M., & Mitra, A. K. (1993) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1993.9.299 · Cited by 38 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Schoenwald RD, Tandon V, Wurster DE, Barfknecht CF. Significance of melanin binding and metabolism in the activity of 5-acetoxyacetylimino-4-methyl-delta2-1, 3, 4,-thiadiazolin e-2- sulfonamide. Eur J Pharm Biopharm. 1998;46(1):39-50.
Cited by
Sorted by citations
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 894 · see citing works
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 869 · see citing works
Emerging Targets in Photopharmacology
Lerch, M. M., Hansen, M. J., van Dam, G. M., Szymański, W., & Feringa, B. L. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601931 · Cited by 674 · see citing works
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 622 · see citing works
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 523 · see citing works
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481 · see citing works
Self-citationA comprehensive insight on ocular pharmacokinetics
Agrahari, V., Mandal, A., Agrahari, V., Trinh, H. M., Joseph, M. A., Ray, A., Hadji, H., Mitra, R., Pal, D., & Mitra, A. K. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0339-2 · Cited by 465 · see citing works
Self-citationOcular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441 · see citing works
Bachu, R. D., Chowdhury, P., Al-Saedi, Z. H. F., Karla, P. K., & Boddu, S. H. S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010028 · Cited by 425 · see citing works
Eskandari, S., Guerin, T., Tóth, I., & Stephenson, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.013 · Cited by 384 · see citing works
Varela‐Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García‐Otero, X., Álvarez, A. L., Fernández‐Ferreiro, A., & Otero-Espinar, F. J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030269 · Cited by 363 · see citing works
Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Onugwu, A. L., Nwagwu, C. S., Onugwu, S. O., Echezona, A. C., Agbo, C. P., Ihim, S. A., Emeh, P., Nnamani, P. O., Attama, A. A., & Khutoryanskiy, V. V. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.018 · Cited by 356 · see citing works
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 348 · see citing works
Than, A., Liu, C., Chang, H., Duong, P. K., Cheung, C. M. G., Xu, C., Wang, X., & Chen, P. (2018) · Nature Communications · doi:10.1038/s41467-018-06981-w · Cited by 347 · see citing works
Nanoparticles for drug delivery to the anterior segment of the eye
Janagam, D. R., Wu, L., & Lowe, T. L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.001 · Cited by 343 · see citing works
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang, K., Zhang, L., & Weinreb, R. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3745 · Cited by 316 · see citing works
Vascular permeability—the essentials
Claesson, L. (2015) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2015.1064501 · Cited by 304 · see citing works
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 309 · see citing works
Zhai, J., Fong, C., Tran, N. L., & Drummond, C. J. (2019) · ACS Nano · doi:10.1021/acsnano.8b07961 · Cited by 281 · see citing works
A review on therapeutic contact lenses for ocular drug delivery
Maulvi, F. A., Soni, T. G., & Shah, D. O. (2016) · Drug Delivery · doi:10.3109/10717544.2016.1138342 · Cited by 271 · see citing works
Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
Rzhevskiy, A. S., Singh, T. R. R., Donnelly, R. F., & Anissimov, Y. G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.048 · Cited by 267 · see citing works
Gaballa, S. A., Kompella, U. B., Elgarhy, O., Alqahtani, A. M., Pierscionek, B., Alany, R. G., & Abdelkader, H. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00843-z · Cited by 255 · see citing works
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review
Mura, P., Maestrelli, F., Cirri, M., & Mennini, N. (2022) · Marine Drugs · doi:10.3390/md20050335 · Cited by 255 · see citing works
Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
Tsai, C.-H., Wang, P., Lin, I., Hu, H., Liu, G., & Tseng, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092830 · Cited by 241 · see citing works
Non-viral gene therapy: Gains and challenges of non-invasive administration methods
Földvári, M., Chen, D.-W., Nafissi, N., Calderon-Nieva, D., Narsineni, L., & Rafiee, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.012 · Cited by 240 · see citing works
Ocular delivery of macromolecules
Kim, Y. C., Chiang, B., Wu, X., & Prausnitz, M. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.043 · Cited by 236 · see citing works
Hydrogel Biomaterials for Application in Ocular Drug Delivery
Lynch, C. R., Kondiah, P. P. D., Choonara, Y. E., du Toit, L. C., Ally, N., & Pillay, V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00228 · Cited by 234 · see citing works
Overcoming ocular drug delivery barriers through the use of physical forces
Huang, D., Chen, Y.-S., & Rupenthal, I. D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.008 · Cited by 230 · see citing works
Liposomes for intravitreal drug delivery: A state of the art
Bochot, A., & Fattal, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.019 · Cited by 229 · see citing works
Key advances of carboxymethyl cellulose in tissue engineering & 3D bioprinting applications
Zennifer, A., Senthilvelan, P., Sethuraman, S., & Sundaramurthi, D. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117561 · Cited by 229 · see citing works
Thermosensitive Hydrogels and Advances in Their Application in Disease Therapy
Fan, R., Cheng, Y., Wang, R., Zhang, T., Zhang, H., Li, J., Song, S., & Zheng, A. (2022) · Polymers · doi:10.3390/polym14122379 · Cited by 228 · see citing works
A review on recent drug delivery systems for posterior segment of eye
Nayak, K., & Misra, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.138 · Cited by 228 · see citing works
Principles of pharmacology in the eye
Awwad, S., Mohamed Ahmed, A. H. A., Sharma, G., Heng, J. S., Khaw, P. T., Brocchini, S., & Lockwood, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14024 · Cited by 224 · see citing works
Masuda, T., Shimazawa, M., & Hara, H. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9208489 · Cited by 221 · see citing works
A comprehensive review on contact lens for ophthalmic drug delivery
Xu, J., Xue, Y., Hu, G., Lin, T., Gou, J., Yin, T., He, H., Zhang, Y. X., & Tang, X. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.020 · Cited by 214 · see citing works
Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System
Akhter, M. H., Ahmad, I. S., Alshahrani, M. Y., Al-Harbi, A. I., Khalilullah, H., Afzal, O., Altamimi, A. S. A., Ullah, S. N. M. N., Ojha, A., & Karim, S. (2022) · Gels · doi:10.3390/gels8020082 · Cited by 212 · see citing works
Cyclodextrin‐Based Formulations: A Non‐Invasive Platform for Targeted Drug Delivery
Muankaew, C., & Loftsson, Þ. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12917 · Cited by 204 · see citing works
Recent Advances in Ocular Drug Delivery Systems
Kuno, N., & Fujii, S. (2011) · Polymers · doi:10.3390/polym3010193 · Cited by 202 · see citing works
Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease
Perez, V. L., Pflugfelder, S. C., Zhang, S., Shojaei, A., & Haque, R. M. (2016) · The Ocular Surface · doi:10.1016/j.jtos.2016.01.001 · Cited by 200 · see citing works
Applications of Chitosan-Alginate-Based Nanoparticles—An Up-to-Date Review
Niculescu, A.-G., & Grumezescu, A. M. (2022) · Nanomaterials · doi:10.3390/nano12020186 · Cited by 199 · see citing works
Hyaluronic acid in ocular drug delivery
Zhang, X., Wei, D., Xu, Y., & Zhu, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118006 · Cited by 196 · see citing works
Balguri, S. P., Adelli, G. R., & Majumdar, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.015 · Cited by 195 · see citing works
Kauper, K. A., McGovern, C., Sherman, S., Heatherton, P., Rapoza, R., Stabila, P. F., Dean, B., Lee, A., Borges, S., Bouchard, B., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9970 · Cited by 193 · see citing works
Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
Souto, E. B., Dias-Ferreira, J., López-Machado, A., Ettcheto, M., Cano, A. C., Camins, A., Espina, M., García, M. L., & Sánchez‐López, E. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090460 · Cited by 196 · see citing works
Khames, A., Khaleel, M. A., El‐Badawy, M. F., & El‐Nezhawy, A. O. H. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s190502 · Cited by 192 · see citing works
Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
Zamboulis, A., Nanaki, S. G., Michailidou, G., Koumentakou, I., Lazaridou, M., Ainali, N. M., Xanthopoulou, E., & Bikiaris, D. Ν. (2020) · Polymers · doi:10.3390/polym12071519 · Cited by 190 · see citing works
Novel Strategies for Anterior Segment Ocular Drug Delivery
Cholkar, K., Patel, S. P., Vadlapudi, A. D., & Mitra, A. K. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0200 · Cited by 189 · see citing works
Self-citationMofidfar, M., Abdi, B., Ahadian, S., Mostafavi, E., Desai, T. A., Abbasi, F., Sun, Y., Manche, E. E., Ta, C. N., & Flowers, C. W. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120924 · Cited by 187 · see citing works
Singh, M. V., Bharadwaj, S., Lee, K. E., & Kang, S. G. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.025 · Cited by 184 · see citing works
Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review
Dubald, M., Bourgeois, S., Andrieu, V., & Fessi, H. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010010 · Cited by 176 · see citing works
Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases
Peng, Y., Tang, L., & Zhou, Y. (2017) · Ophthalmic Research · doi:10.1159/000479157 · Cited by 175 · see citing works
Minimally invasive microneedles for ocular drug delivery
Singh, R. R. T., Tekko, I. A., McAvoy, K., McMillan, H. L., Jones, D. S., & Donnelly, R. F. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1218460 · Cited by 173 · see citing works
Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems
Madamsetty, V. S., Mohammadinejad, R., Uzielienè, I., Nabavi, N., Dehshahri, A., García-Couce, J., Tavakol, S., Moghassemi, S., Dadashzadeh, A., Makvandi, P., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00026 · Cited by 173 · see citing works
Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview
Almeida, H., Amaral, M. H., Lobão, P., & Lobo, J. M. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.796360 · Cited by 172 · see citing works
Sánchez‐López, E., Espina, M., Doktorovová, S., Souto, E. B., & García, M. L. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.009 · Cited by 172 · see citing works
Luo, L., Nguyen, D. D., & Lai, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119961 · Cited by 172 · see citing works
Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes
McGuckin, M. B., Wang, J., Ghanma, R., Qin, N., Palma, S. D., Donnelly, R. F., & Paredes, A. J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.012 · Cited by 171 · see citing works
Davis, B. M., Normando, E. M., Guo, L., Turner, L., Nizari, S., O’Shea, P., Moss, S. E., Somavarapu, S., & Cordeiro, M. F. (2014) · Small · doi:10.1002/smll.201303433 · Cited by 165 · see citing works
Eye: anatomy, physiology and barriers to drug delivery
Cholkar, K., Dasari, S. R., Pal, D., & Mitra, A. K. (2013) · Elsevier eBooks · doi:10.1533/9781908818317.1 · Cited by 163 · see citing works
Self-citationSynthesis and Potential Applications of Lipid Nanoparticles in Medicine
Musielak, E., Feliczak‐Guzik, A., & Nowak, I. (2022) · Materials · doi:10.3390/ma15020682 · Cited by 161 · see citing works
Tatke, A., Dudhipala, N. R., Janga, K. Y., Balguri, S. P., Avula, B., Jablonski, M. M., & Majumdar, S. (2018) · Nanomaterials · doi:10.3390/nano9010033 · Cited by 160 · see citing works
Development and characterization of nano-fiber patch for the treatment of glaucoma
Gagandeep, Garg, T., Malik, B., Rath, G., & Goyal, A. K. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.11.016 · Cited by 158 · see citing works
Phadatare, S. P., Momin, M. M., Nighojkar, P., Askarkar, S., & Singh, K. K. (2015) · Advances in Pharmaceutics · doi:10.1155/2015/704946 · Cited by 157 · see citing works
Liposomes and nanotechnology in drug development: focus on ocular targets
Honda, M., Asai, Oku, Araki, Tanaka, & Ebihara (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s30725 · Cited by 157 · see citing works
Irimia, T., Ghica, M. V., Popa, L., Anuța, V., Arsene, A., & Dinu‐Pîrvu, C. (2018) · Polymers · doi:10.3390/polym10111221 · Cited by 157 · see citing works
Chetoni, P., Burgalassi, S., Monti, D., Tampucci, S., Tullio, V. C., Cuffini, A., Muntoni, E., Spagnolo, R., Zara, G. P., & Cavalli, R. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.006 · Cited by 151 · see citing works
Cyclodextrin-Mediated Enhancement of Riboflavin Solubility and Corneal Permeability
Morrison, P. W. J., Connon, C. J., & Khutoryanskiy, V. V. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005963 · Cited by 151 · see citing works
Duarah, S., Sharma, M., & Wen, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.01.005 · Cited by 152 · see citing works
Yang, C. G., Wu, Q., Liu, J., Mo, J., Li, X., Yang, C., Liu, Z., Yang, J., Jiang, L., Chen, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29860-x · Cited by 152 · see citing works
Sustained drug release by contact lenses for glaucoma treatment—A review
de Carvalho, I. A., Marques, C. S., Oliveira, R., Coelho, P. B., Costa, P. C., & Ferreira, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.023 · Cited by 149 · see citing works
Advanced drug delivery and targeting technologies for the ocular diseases
Barar, J., Aghanejad, A., Fathi, M., & Omidi, Y. (2016) · Bioimpacts · doi:10.15171/bi.2016.07 · Cited by 148 · see citing works
Contact Lenses: Promising Devices for Ocular Drug Delivery
Guzmán‐Aránguez, A., Colligris, B., & Pintor, J. J. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0212 · Cited by 147 · see citing works
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145 · see citing works
Advancing the stimuli response of polymer-based drug delivery systems for ocular disease treatment
Dung, N. D., & Lai, J. (2020) · Polymer Chemistry · doi:10.1039/d0py00919a · Cited by 145 · see citing works
Nunes, D., Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2022) · Polymers · doi:10.3390/polym14051010 · Cited by 144 · see citing works
Tan, G., Yu, S., Pan, H., Li, J., Liu, D., Yuan, K., Yang, X., & Pan, W. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.10.035 · Cited by 143 · see citing works
Periman, L. M., Mah, F. S., & Karpecki, P. M. (2020) · Clinical ophthalmology · doi:10.2147/opth.s279051 · Cited by 149 · see citing works
Overview of Recent Advances in Nano-Based Ocular Drug Delivery
Liu, L.-C., Chen, Y., & Lu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015352 · Cited by 141 · see citing works
Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye
Loftsson, Þ., & Stefánsson, E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.010 · Cited by 139 · see citing works
Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations
Lanier, O. L., Manfre, M. G., Bailey, C., Liu, Z., Sparks, Z., Kulkarni, S., & Chauhan, A. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-01977-0 · Cited by 139 · see citing works
Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery
Grimaudo, M. A., Pescina, S., Padula, C., Santi, P., Concheiro, A., Alvarez-Lorenzo, C., & Nicoli, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00939 · Cited by 138 · see citing works
Zhang, P., Liu, X., Hu, W., Bai, Y., & Zhang, L. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.04.115 · Cited by 138 · see citing works
Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems
Gupta, B., Mishra, V., Gharat, S., Momin, M. M., & Omri, A. (2021) · Pharmaceuticals · doi:10.3390/ph14111201 · Cited by 138 · see citing works
Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review
Bévalot, F., Cartiser, N., Bottinelli, C., Fanton, L., & Guitton, J. (2015) · Forensic Toxicology · doi:10.1007/s11419-015-0294-5 · Cited by 141 · see citing works
Target strategies for drug delivery bypassing ocular barriers
Suri, R., Beg, S., & Kohli, K. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101389 · Cited by 134 · see citing works
Shah, J., Nair, A. B., Jacob, S., Patel, R. K., Shah, H., Shehata, T. M., & Morsy, M. A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050230 · Cited by 132 · see citing works
Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin
Costa, J. R., Silva, N. C., Sarmento, B. F. C. C., & Pintado, M. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2344-7 · Cited by 130 · see citing works
Fangueiro, J. F., Calpena, A. C., Clares, B., Andreani, T., Egea, M. A., Veiga, F., García, M. L., Silva, A. M., & Souto, E. B. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.039 · Cited by 130 · see citing works
Contact lenses as a platform for ocular drug delivery
Bengani, L. C., Hsu, K.-H., Gause, S., & Chauhan, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.821462 · Cited by 129 · see citing works
In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye
Peynshaert, K., Devoldere, J., Smedt, S. C. D., & Remaut, K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.007 · Cited by 132 · see citing works
Topical delivery of ocular therapeutics: carrier systems and physical methods
de Souza, J. G., Dias, K., Pereira, T. A., Bernardi, D. S., & Lopez, R. F. V. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12132 · Cited by 128 · see citing works
Gándara-Loe, J., Souza, B. E., Missyul, A. B., Durango-Giraldo, G., Tan, J., & Silvestre‐Albero, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c07517 · Cited by 128 · see citing works
Elkhoury, K., Koçak, P., Kang, A., Arab‐Tehrany, E., Ward, J. E., & Shin, S. R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090849 · Cited by 129 · see citing works
Gold nanoparticles in ophthalmology
Masse, F., Ouellette, M., Lamoureux, G., & Boisselier, É. (2018) · Medicinal Research Reviews · doi:10.1002/med.21509 · Cited by 130 · see citing works
Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery
Gupta, H., Velpandian, T., & Jain, S. (2010) · Journal of drug targeting · doi:10.3109/10611860903508788 · Cited by 127 · see citing works
Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle
Jung, J. H., Chiang, B., Grossniklaus, H. E., & Prausnitz, M. R. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.001 · Cited by 126 · see citing works
Nanotechnology approaches for ocular drug delivery
Kannan, R. M., Xu, Q., & Kambhampati, S. P. (2013) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.106384 · Cited by 125 · see citing works
Mastropasqua, L., Nubile, M., Calienno, R., Mattei, P. A., Pedrotti, E., Salgari, N., Mastropasqua, R., & Lanzini, M. (2013) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.11.018 · Cited by 125 · see citing works
Lai, J., & Hsieh, A.-C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.085 · Cited by 125 · see citing works
Herrero‐Vanrell, R., Bravo‐Osuna, I., Andrés‐Guerrero, V., Vicario‐de‐la‐Torre, M., & Molina-Martínez, I. T. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.04.002 · Cited by 124 · see citing works
- Authors
- Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K.
- Affiliations
- University of Missouri–Kansas City (US)
- Corresponding author
- Mitra, Ashim K.
- Venue
- The AAPS Journal
- Published
- 2010-05-01
- Volume
- 12
- Issue
- 3
- Pages
- 348-360
- ISSN
- 1550-7416 (ISSN-L)
- PMC
- PMC2895432
- OpenAlex
- W2018516156
- Cited by
- 1,406
- References
- 256
- Citations by year
- 2026: 114 · 2025: 114 · 2024: 98 · 2023: 118 · 2022: 110 · 2021: 126 · 2020: 116 · 2019: 93 · 2018: 100 · 2017: 96 · 2016: 82 · 2015: 60 · 2014: 54 · 2013: 58 · 2012: 32
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The AAPS Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY009171, R01EY10659-12, R01EY010659, R01-EY09171-14)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- ocular drug delivery, blood-aqueous barrier, blood-retinal barrier, cornea, sclera, retina, choroidal blood flow, lymphatic clearance, efflux pumps, influx transporters, nanoparticles, nanomicelles, liposomes, microemulsions, bioadhesive gel, fibrin glue, sustained drug release, topical drug delivery, posterior segment, anterior segment
- MeSH terms
- Administration, Topical, Colloids, Eye, Half-Life, Humans, Iontophoresis, Melanins, Pharmacokinetics, Ultrasonics, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review